NEWS

Tuberculosis in Australia and Low-Incidence Countries

Two recent publications from TB-CRE investigators highlight the challenges and opportunities in TB control in migrants in low-incidence...

4.25 million for TB control in the Pacific

A team of TB-CRE researchers and affiliates led by Professor Ben Marais have been awarded $4.25 million in MRFF funding to pave a pathway...

Genetic Testing for Multi-drug Resistant Tuberculosis

GeneXpert, a rapid genetic test for the detection of tuberculosis infection has announced a new Xpert to simultaneously test for MDR/XDR...

The Ethical Landscape of TB control

In a special issue, the International Journal of Tuberculosis and Lung Disease recently released a series of articles addressing the...

WHO urges oral treatment regimens for drug-resistant TB

This week the WHO has updated their guidelines, recommending shorter and fully oral treatment regimens for patients with MDR-TB The...

WHO Guidelines on Tuberculosis Preventative Therapy

TB-CRE Investigator Steve Graham works with WHO to develop 18 recommendations for TB preventative therapy. On the 24th of March, the WHO...

The UNION COVID-19 Webinar Series

The International UNION against TB and Lung Disease has launched a highly informative webinar series looking at the complications of...

Modelling shows devastating impact of COVID-19 on TB

The STOP TB Partnership has recently released modelling which predicts an additional 6.8 million TB cases between 2020 and 2025, possibly...

World TB Day Publications by TB-CRE Researchers

The TB-CRE is delighted to highlight recent publications in Lancet Respiratory Medicine by our researchers for World TB Day last month....

History of Tuberculosis Control in Australia: an NHMRC case study

TB-CRE researchers examine how Australia became a low TB incidence country in a recent NHMRC case study

TB control community mourns loss of colleagues to COVID-19

With deepest sadness, the TB community faces the loss of three highly valued colleagues in the Asia-Pacific due to COVID-19...

Lancet Systematic Review: Disease risk & preventive therapy for TB-exposed infants & young children

TB-CRE investigators provide recent data of the risk of tuberculosis and benefits of preventive therapy in children following close...